Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.08 USD | -2.26% | -4.42% | +28.80% |
Business Summary
Number of employees: 93
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paula Ragan
FOU | Founder | 54 | 09-12-31 |
Adam Mostafa
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Mary DiBiase
COO | Chief Operating Officer | 63 | 16-12-31 |
Chief Tech/Sci/R&D Officer | - | 23-07-31 | |
Art Taveras
CTO | Chief Tech/Sci/R&D Officer | 60 | 20-11-01 |
Murray Stewart
BRD | Director/Board Member | 63 | 19-03-28 |
Brian Bowersox
PRN | Corporate Officer/Principal | - | - |
Mark Baldry
PRN | Corporate Officer/Principal | - | 22-10-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 18-06-30 |
David McGirr
BRD | Director/Board Member | 69 | 17-08-31 |
Paula Ragan
FOU | Founder | 54 | 09-12-31 |
Gary Bridger
BRD | Director/Board Member | 61 | 18-09-30 |
Alison Lawton
BRD | Director/Board Member | 62 | 20-10-04 |
Bill Aliski
BRD | Director/Board Member | 75 | 19-09-17 |
Director/Board Member | 62 | 21-10-13 | |
Murray Stewart
BRD | Director/Board Member | 63 | 19-03-28 |
R. Woods
BRD | Director/Board Member | 57 | 23-10-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 167,937,781 | 162,995,043 ( 97.06 %) | 0 | 97.06 % |
Company contact information
X4 Pharmaceuticals, Inc.
61 North Beacon Street 4th floor
02134, Boston
+857 529 8300
http://www.x4pharma.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.80% | 181M | |
-1.65% | 103B | |
+6.75% | 101B | |
+6.64% | 23.07B | |
-12.60% | 22.23B | |
-5.20% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- XFOR Stock
- Company X4 Pharmaceuticals, Inc.